Roles of heparan-sulphate glycosaminoglycans in cancer (Q34718195)

4 August 2017

1 reference

title

Roles of heparan-sulphate glycosaminoglycans in cancer (English)

1 reference

4 August 2017

Ram Sasisekharan

1

1 reference

4 August 2017

Zachary Shriver

series ordinal

2

1 reference

4 August 2017

Ganesh Venkataraman

series ordinal

3

1 reference

4 August 2017

Uma Narayanasami

series ordinal

4

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

4 August 2017

published in

Nature Reviews Cancer

1 reference

4 August 2017

volume

2

1 reference

4 August 2017

issue

7

1 reference

4 August 2017

page(s)

521-528

1 reference

Specificities of heparan sulphate proteoglycans in developmental processes

4 August 2017

cites work

1 reference

Dynamic regulation of tumor growth and metastasis by heparan sulfate glycosaminoglycans

31 March 2020

1 reference

Heparan sulfate: growth control with a restricted sequence menu

31 March 2020

1 reference

Molecular diversity of heparan sulfate

31 March 2020

1 reference

Heparan sulfate: decoding a dynamic multifunctional cell regulator

31 March 2020

1 reference

Heparin and heparan sulfate: biosynthesis, structure and function

31 March 2020

1 reference

Diversity does make a difference: fibroblast growth factor-heparin interactions

31 March 2020

1 reference

The anticoagulant activation of antithrombin by heparin

31 March 2020

1 reference

Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization

31 March 2020

1 reference

Structure of a heparin-linked biologically active dimer of fibroblast growth factor

31 March 2020

1 reference

Order out of complexity--protein structures that interact with heparin

31 March 2020

1 reference

Differential ability of heparan sulfate proteoglycans to assemble the fibroblast growth factor receptor complex in situ

31 March 2020

1 reference

Developmental Regulation of Neural Response to FGF-1 and FGF-2 by Heparan Sulfate Proteoglycan

31 March 2020

1 reference

Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase

31 March 2020

1 reference

Improved cancer mortality with low-molecular-weight heparin treatment: a review of the evidence

31 March 2020

1 reference

Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis

31 March 2020

1 reference

Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans

31 March 2020

1 reference

Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis

31 March 2020

1 reference

Heparan sulfate proteoglycans and cancer.

31 March 2020

1 reference

Glypican-3 expression is silenced in human breast cancer

31 March 2020

1 reference

Glypicans in growth control and cancer

31 March 2020

1 reference

Heparan sulfate proteoglycans in invasion and metastasis

31 March 2020

1 reference

Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro.

31 March 2020

1 reference

Simpson Golabi Behmel syndrome: progress toward understanding the molecular basis for overgrowth, malformation, and cancer predisposition

31 March 2020

1 reference

Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas

31 March 2020

1 reference

Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2.

31 March 2020

1 reference

Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena

31 March 2020

1 reference

Angiogenesis-dependent diseases

31 March 2020

1 reference

Heparinase inhibits neovascularization

31 March 2020

1 reference

Cell surface glypicans are low-affinity endostatin receptors

31 March 2020

1 reference

Role of sinusoidal heparan sulfate proteoglycan in liver metastasis formation

31 March 2020

1 reference

Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis

31 March 2020

1 reference

Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis

31 March 2020

1 reference

Antithrombotic therapy in cancer

31 March 2020

1 reference

Low-molecular-weight heparin and cancer

31 March 2020

1 reference

Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites

31 March 2020

1 reference

Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development

31 March 2020

1 reference

Inhibitors of angiogenesis selectively reduce the malignant cell load in rodent models of human myeloid leukemias

31 March 2020

1 reference

Poly(N-acryl amino acids): A New Class of Biologically Active Polyanions

31 March 2020

1 reference

Toward a biotechnological heparin through combined chemical and enzymatic modification of the Escherichia coli K5 polysaccharide

31 March 2020

1 reference

Tumor attenuation by combined heparan sulfate and polyamine depletion.

31 March 2020

1 reference

Highly sensitive sequencing of the sulfated domains of heparan sulfate.

31 March 2020

1 reference

A strategy for rapid sequencing of heparan sulfate and heparin saccharides

31 March 2020

1 reference

Sequencing complex polysaccharides

31 March 2020

1 reference

Direct isolation and sequencing of specific protein-binding glycosaminoglycans

31 March 2020

1 reference

Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis

31 March 2020

1 reference

Experimental Proof for the Structure of a Thrombin-Inhibiting Heparin Molecule

31 March 2020

1 reference

Role of heparan sulfate proteoglycans in the uptake and degradation of tissue factor pathway inhibitor-coagulation factor Xa complexes

31 March 2020

1 reference

Fibroblast growth factor-2.

31 March 2020

1 reference

Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma

31 March 2020

1 reference

Dally cooperates with Drosophila Frizzled 2 to transduce Wingless signalling

31 March 2020

1 reference

The cell-surface proteoglycan Dally regulates Wingless signalling in Drosophila

31 March 2020

1 reference

Heparan sulfate-like proteoglycans mediate adhesion of human malignant melanoma A375 cells to P-selectin under flow

31 March 2020

1 reference

Cell type-specific differences in glycosaminoglycans modulate the biological activity of a heparin-binding peptide (RKRLQVQLSIRT) from the G domain of the laminin alpha1 chain

31 March 2020

1 reference

A unique sequence of the laminin alpha 3 G domain binds to heparin and promotes cell adhesion through syndecan-2 and -4

31 March 2020

1 reference

Perlecan inhibits smooth muscle cell adhesion to fibronectin: role of heparan sulfate

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC842

1 reference

Dimensions Publication ID

4 August 2017

1025937911

0 references

1 reference